Citations

Showing 10 of 108104 citations.

Practice‐relevant demarcation of systemic mastocytosis associated with another hematologic neoplasm
Tefferi, Ayalew , Shah, Sahrish, Patnaik, Mrinal M. , Reichard, Kaaren K. , Hanson, Curtis A. , Pardanani, Animesh , Lasho, Terra L. , Patnaik, Mrinal , Ketterling, Rhett P.

Mayo Clinic

American Journal of Hematology | August 30, 2018 | Volume: 93 | Issue: 12 | Pages: No page available

10.1002/ajh.25269 | PMID 30156701 Get It

Etiologies and characteristics of refractory status epilepticus cases in different areas of the world: Results from a global audit
Ferlisi, Monica , Hocker, Sara E. , Trinka, Eugen , O’Brien, Terence J. , Cook, Mark , Leitinger, Markus , Newton, Charles R. , Giovannini, Giada , Hocker, Sara, Cook, Mark J , Trinka, Eugen , Shorvon, Simon D.

Mayo Clinic

Epilepsia | August 30, 2018 | Volume: 59 | Issue: S2 | Pages: 100-107

10.1111/epi.14496 | PMID 30159876 Get It

Summary To describe the demographics, etiologies, types of status epilepticus ( SE ), and outcomes in people with refractory and super‐refractory SE from around the world, we prospectively collected cases of refractory SE ( RSE ) treated with continuous intravenous anesthetic drugs in an intensive care unit setting through online questionnaires using “active surveillance.” We collected information about 776 cases of RSE in 50 countries over 4 years. Control of SE was achieved in 74% of the cases. Neurologic outcomes were poor in 41% of patients, and 24% died. Good outcome was associated with younger age and a history of epilepsy. Etiology strongly influenced the outcome. Patients from Asia were younger, more frequently presented with convulsive SE , and were more frequently affected by infectious etiologies when compared with patients from Europe and the Americas. Despite these differences, outcomes were similar in all countries. Demographics of patients with RSE in a global audit are similar to those in prior single center series, providing evidence of generalizability of those studies. Important differences exist among patients with RSE from different regions of the world, but these do not seem to significantly influence patient outcomes.
P1614Right ventricular and pulmonary vascular function indices for risk stratification of patients with pulmonary regurgitation
Egbe, Alexander C. , Sharma, Naveen , El‐Harasis, Majd , Alotaibi, Mona , Sharma, N

Mayo Clinic

European Heart Journal | August 30, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy565.p1614 Get It

Quantitative T2 MRI Mapping and 12-Month Follow-up in a Randomized, Blinded, Placebo Controlled Trial of Bone Marrow Aspiration and Concentration for Osteoarthritis of the Knees
Arthurs, Jennifer R. , Kazmerchak, Shari E. , Diehl, Nancy N. , O’Connor, Mary I. , Bestic, Joseph M. , O'Connor, Mary I , Shapiro, Shane A. , Heckman, Michael G. , Zubair, Abba C.

Mayo Clinic

CARTILAGE | August 30, 2018 | Volume: 10 | Issue: 4 | Pages: 432-443

10.1177/1947603518796142 | PMID 30160168 Get It

Objective Bone marrow aspiration and concentration (BMAC) is becoming a more common regenerative therapy for musculoskeletal pathology. In our current pilot study, we studied patients with mild-to-moderate bilateral knee osteoarthritis, compared pain at 12-month follow-up between BMAC-injected and saline-injected knees, and examined cartilage appearance measured by magnetic resonance imaging (MRI) T2 quantitative mapping. Design Twenty-five patients with mild-to-moderate bilateral osteoarthritic knee pain were randomized to receive BMAC into one knee and saline placebo into the other. Bone marrow was aspirated from the iliac crests, concentrated in an automated centrifuge, combined with platelet-poor plasma for knee injection, and compared with saline injection into the contralateral knee. Primary outcome measures were T2 MRI cartilage mapping at 6-month and Visual Analog Scale and Osteoarthritis Research Society International Intermittent and Constant Osteoarthritis Pain scores and radiographs at 12-month follow-up. Results Constant, intermittent, and overall knee pain remained significantly decreased from baseline at 12-month follow-up (all P ⩽ 0.01), with no apparent difference between BMAC- and saline-treated knees (all P ⩾ 0.54). A similar significant increase from baseline to 12-month follow-up regarding quality of life was observed for both BMAC- and saline-treated knees (all P ⩽ 0.04). T2 quantitative MRI mapping showed no significant changes as a result of treatment. Conclusions BMAC is safe to perform and relieves pain from knee arthritis but showed no superiority to saline injection at 12-month follow-up. MRI cartilage sequences failed to show regenerative benefit with single BMAC injection. The mechanisms of action that led to pain relief remain unclear and warrant further studies.
P3698Correlation of lead length with procedural safety outcomes of magnetic resonance imaging in patients with legacy pacemakers and defibrillators
Padmanabhan, Deepak , Naksuk, Niyada , Deshmukh, Abhishek , Mulpuru, Siva K. , Felmlee, Joel P. , Dalzell, Connie, Olson, Nora E., Jondal, Mary Lou, Watson, Robert E. , Cha, Y, Friedman, Paul A. , Kella, Danesh , Isath, Ameesh , Kapa, Suraj , Asirvatham, Samuel J.

Mayo Clinic

European Heart Journal | August 30, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy563.p3698 Get It

P4582Tricuspid valve regurgitation in patients with constrictive pericarditis
Calderon-Rojas, Rolando , Greason, Kevin L. , Oh, J K, Maltais, S., Bagameri, Gabor, Cicek, S, Stulak, John M., Daly, Richard C. , Pochettino, Alberto , Crestanello, Juan A. , Cicek, S, Said, Sameh M. , Schaff, Hartzell V.

Mayo Clinic

European Heart Journal | August 30, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy563.p4582 Get It

3355Meta-analysis of use of proton pump inhibitors with dual antiplatelet therapy after acute coronary syndrome
Lone, Ajaz Ahmad, Riaz, Haroon , Lone, A, Khan, Safi U. , Riaz, H, Riaz, Irbaz Bin , Kaluski, Edo

Mayo Clinic

European Heart Journal | August 30, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy563.3355 Get It

Breast cancer in adolescents and young adults
Johnson, Rebecca H. , Anders, Carey K. , Ruddy, Kathryn J. , Bleyer, Archie , Bleyer, Archie , Litton, Jennifer K.

Mayo Clinic

Pediatric Blood & Cancer | August 30, 2018 | Volume: 65 | Issue: 12 | Pages: No page available

10.1002/pbc.27397 | PMID 30156052 Get It

AbstractBreast cancer is the most common cancer of adolescents and young adult (AYA) women aged 15 to 39 years, accounting for 5.6% of all invasive breast cancer in women. In comparison with older women, AYAs are more likely to have familial cancer predisposition genes, larger breast tumors, unfavorable biological characteristics, distant metastatic disease at diagnosis, and adverse outcome. Endocrine therapy and some chemotherapy recommendations differ between young and older women. AYAs require coordinated multidisciplinary care, treatment regimens that minimize late effects such as premature menopause and osteoporosis, and proactive management of psychological and sexual health during and after cancer treatment.
4994Transcatheter versus surgical aortic valve replacement in patients with prior cardiac surgery in the randomized PARTNER 2A Trial
Chen, S, Redfors, Björn , Ben‐Yehuda, Ori , Crowley, Aaron , Greason, Kevin L. , Finn, Matthew , Vahl, Torsten , Thourani, Vinod H. , Suri, Rakesh M. , Svensson, Lars G. , Webb, John G. , Kodali, Susheel , Leon, M.B., Investigators, the PARTNER 2 Trial, Alu, Maria C. , Nazif, Tamim , Investigators, the PARTNER 2 Trial

Mayo Clinic

European Heart Journal | August 30, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy566.4994 Get It

P3720Use of comprehensive 2D speckle tracking echocardiography for differentiating left ventricular hypertrophy (LVH): a pilot study
Mesa, Juan Simon Rico, Nhola, Lara F., Calle, Maria C. Arciniegas, Villarraga, Hector R.

Mayo Clinic

European Heart Journal | August 30, 2018 | Volume: 39 | Issue: suppl_1 | Pages: No page available

10.1093/eurheartj/ehy563.p3720 Get It